Epi-Allele elicits compensatory expression of the non-targeted allele and prevents haploinsufficiency in dominant genetic diseases.

Epi-Allele epigenetic editing induces compensatory non-targeted allele expression, preventing haploinsufficiency in dominant genetic diseases, with potential for broad therapeutic use.

• Why it matters: Haploinsufficiency limits current allele-specific therapies for dominant diseases, risking insufficient gene dosage. Understanding and harnessing allele-specific regulation could improve treatment safety and efficacy.
• What they did: Researchers developed Epi-Allele, an epigenetic editing method targeting pathogenic alleles, and performed genome-wide screening, demonstrating widespread compensatory expression of non-targeted alleles in various genes.
• The result: This approach successfully balanced gene expression in models of hypertrophic cardiomyopathy, suggesting it can prevent haploinsufficiency and serve as a precise, allele-specific therapy for dominant genetic disorders.